What is the fair value of Clorox Co (NYSE-CLX) stock?

The current fair value estimate for Clorox Co (NYSE-CLX) is $105.71. This implies an estimated upside of 22.3% versus the current market price.

Is Clorox Co (NYSE-CLX) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 22.3% versus the current market price.

What is the analyst price target for NYSE-CLX stock?

The available analyst price target for Clorox Co (NYSE-CLX) is $96.35. The analyst target implies estimated upside of 11.5%.

How is the financial health of Clorox Co?

The current financial health read for Clorox Co (NYSE-CLX) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Does Clorox Co (NYSE-CLX) pay dividends?

Based on the current data, dividend yield is 5.8%, payment date is November 13, 2026.

What is the P/E ratio for Clorox Co (NYSE-CLX)?

The current P/E ratio listed for Clorox Co (NYSE-CLX) is 17.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Clorox Co?

The current market capitalization listed for Clorox Co is 10.448 B.

What is the enterprise value of Clorox Co?

The current enterprise value listed for Clorox Co is 16.065 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Clorox Co?

The ticker symbol for Clorox Co is NYSE-CLX, and the stock is listed on NYSE.

Where is Clorox Co (NYSE-CLX) listed?

Clorox Co (NYSE-CLX) is listed on NYSE.

What is the debt-to-total-capital ratio for Clorox Co?

The current debt-to-total-capital ratio listed for Clorox Co is 34.5%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Clorox Co?

The free float listed for Clorox Co is 99.6%. Free float helps investors understand how much of the share base is available for public trading.

Clorox Co (CLX) Fair Value & Stock Analysis

Clorox Co (CLX)

Clorox Co is a consumer staples company listed on the NYSE as common stock. Through its operations, the company makes and markets household and professional products in the United States and abroad. Its business is organized into four segments: Health and Wellness, Household, Lifestyle, and International.

The company’s portfolio includes cleaning, disinfecting, laundry, food, water-filtration, grilling, pet care, and personal care products, along with vitamins and supplements. Brands associated with these categories include Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, Formula 409, CloroxPro, Clorox Healthcare, Fresh Step, Scoop Away, Glad, Kingsford, Hidden Valley, Brita, Burt’s Bees, Ever Clean, Clorinda, Chux, Natural Vitality, RenewLife, NeoCell, and Rainbow Light. Clorox sells through a range of retail channels, e-commerce, and distributors. The company was founded in 1913 and is headquartered in Oakland, California.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Payment Date	Dividend Yield	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NYSE-CLX	$105.71	22.3% Upside	Undervalued	$96.35	11.5% Upside	Fair	Fair	November 13, 2026	5.8%	17.8x	116.1x	1.6x	10.448 B	16.065 B	34.5%	99.6%	3.0	102.6%	69.0%